Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol/Pfizer's Eliquis Better For Preventing Strokes And Bleeding In Large Real-World Trial

Executive Summary

In Bristol/Pfizer's ARISTOPHANES real-world study, the rate of major bleeding with Eliquis was 46% lower than J&J/Bayer's Xarelto and 33% lower than Boehringer's Pradaxa.

Advertisement

Related Content

Opdivo And Eliquis Carry Bristol’s Q1; Company Continues To Defend IO Strategy
Pharma Q1 Results Preview: Shire, AbbVie, Bristol, Sanofi, Allergan
Portola May Need Randomized Trial For AndexXa Approval. The Question Is When
Deal Watch: Roche Goes All-In On Real-World Data With Flatiron Acquisition
Tackling RWE Challenges To Demonstrate Healthcare Value
NOAC Costs Weigh Heavy In Europe, Unmet Needs Remain
More Pressure On Pradaxa? US Payers May Narrow Coverage Of NOACs
Will Real-World Data Sway Course Of Novel Anticoagulant Market?
CVS Expands Formulary Exclusions In 2017, Express Scripts’ Tally Unchanged

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100543

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel